NCI Could Fund Some Challenge Grants That Miss NIH Funding, Director Says
NCI to Spend 40 Percent of Stimulus Funds On Contracts
Emory Stops Patient Accrual After Discovering Problems In Management
Arizona Cancer Center Wins Core Grant Renewal
Obama Signs Bill Giving FDA Authority Over Tobacco Products
PhRMA Offers Assistance For Part D “Doughnut Hole”
Trending Stories
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









